Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Mai 2021 07:00 ET | Quelle: Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Successful Pre-BLA Meeting with U.S. FDA for AT-GAA for the Treatment of Pompe Disease

Existing Data Support Regulatory Submissions Submissions to Seek Approval in both ERT Naïve and ERT Switch Pompe Patients Completion of Rolling Biologics License Application On-Track by end of 2Q21...
03. Mai 2021 07:00 ET | Quelle: Passage Bio

Passage Bio Partners with InformedDNA® to Offer Genetic Counseling and Testing for Patients with Frontotemporal Dementia (FTD), a Form of Early Onset Dementia

No-cost genetic screening and counseling program aimed at identifying FTD patients who have certain inherited genetic mutations to guide early treatment intervention and awareness of clinical...
03. Mai 2021 07:00 ET | Quelle: DSP Group, Inc.

DSP Group, Inc. Reports First Quarter 2021 Results

First quarter revenues of $32.6 million, 16% YoY growthRecord IoAT revenues of 20.8 million, 14% YoY growthRecord non-GAAP gross margins of 52.7% SAN JOSE, Calif., May 03, 2021 (GLOBE NEWSWIRE) --...
03. Mai 2021 07:00 ET | Quelle: Hookipa Pharma Inc

HOOKIPA Pharma to Report First Quarter 2021 Financial Results on Wednesday, May 12, 2021

NEW YORK and VIENNA, Austria, May 03, 2021 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
03. Mai 2021 07:00 ET | Quelle: Iveda

Iveda Resumes $1.7 Million Contract from Chunghwa Telecom/Farglory Dome

Mesa, Ariz., May 03, 2021 (GLOBE NEWSWIRE) -- Iveda® (OTCMKTS: IVDA), today announced that Taipei’s NTD 47 million (~US $1.7 million) Farglory Dome project is back on track. Chunghwa Telecom,...
03. Mai 2021 07:00 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor Day

SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- At its 2021 Investor Day, Myriad Genetics, Inc. (NASDAQ: MYGN), today will provide a strategic business update, including an overview of initiatives...
03. Mai 2021 07:00 ET | Quelle: Hutchison China MediTech Limited

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) today announces that it completed the rolling...
03. Mai 2021 07:00 ET | Quelle: Cabaletta Bio

Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial

– No dose limiting toxicities (DLTs) or clinically relevant adverse events observed in the first dose cohort as of April 30, 2021 – – Second dose cohort to be initiated after the third patient...
03. Mai 2021 07:00 ET | Quelle: BioXcel Therapeutics

BioXcel Therapeutics to Host First Quarter 2021 Operating and Financial Results Conference Call and Webcast

NEW HAVEN, Conn., May 03, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial...
03. Mai 2021 07:00 ET | Quelle: BurgerFi International

BurgerFi Names Henry Gonzalez as Chief Marketing Officer

PALM BEACH, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- BurgerFi International Inc. (Nasdaq: BFI, BFIIW), one of the nation’s fastest-growing premium fast-casual concepts, QSR’s 2020 Breakout Brand of...

Vorherige Seite

Nächste Seite